Carlo Giovanni Medici
Chief Executive Officer at Alzeca Biosciences, Inc.
Profile
Carlo Giovanni Medici is currently the Chief Executive Officer & Director at Ikonisys, Inc., the Chief Executive Officer & Director at Alzeca Biosciences, Inc., and a Director at Bracco Imaging Scandinavia AB.
In the past, he was the Chief Executive Officer of Bellco Srl from 2013 to 2015, President & Chief Executive Officer of Bracco Diagnostics, Inc., President of Roche Diagnostic Systems, Inc., Vice President & General Manager of Fortrea Clinical Research Unit, Inc., and Head-Global Commercial Operations of Bracco Imaging SpA.
He received his undergraduate degree from the University of Milan.
Carlo Giovanni Medici active positions
| Companies | Position | Start |
|---|---|---|
Bracco Imaging Scandinavia AB
 Bracco Imaging Scandinavia AB Medical SpecialtiesHealth Technology Bracco Imaging Scandinavia AB manufactures and distributes diagnostics equipment. The company was founded in 2006 and is headquartered in Gothenburg, Sweden. | Director/Board Member | 2010-12-12 |
Ikonisys, Inc.
 Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Chief Executive Officer | - |
Alzeca Biosciences, Inc.
 Alzeca Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alzeca Biosciences, Inc. is a company based in Houston, TX. Alzeca is developing a proprietary intravenous contrast agent that targets Alzheimer's disease pathology. The company's targeted agent has shown the ability to detect early stage disease pathology with exceptional resolution and sensitivity using commonly available imaging techniques. The development of the agent was initiated through a collaboration between Dr. Ananth Annapragada and Dr. Jason Eriksen. The company was founded in 2012 by Jason Eriksen, Robin Mansukhani, Ananth Annapragada. The CEO is Carlo Giovanni Medici. | Chief Executive Officer | - |
Former positions of Carlo Giovanni Medici
| Companies | Position | End |
|---|---|---|
Bellco SRL
 Bellco SRL Medical SpecialtiesHealth Technology Bellco SRL provides therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure. It offers haemodiafiltration therapies, dialysis machines equipment, haemodialysers, blood lines, catheters, concentrates, and sorbent cartridges; pathologies for acute patients; and altered haemodynamics, renal hypoperfusion, and low cardiac output therapeutic system for neonatal patients. The company was founded in 1972 and is headquartered in Mirandola, Italy.^ | Chief Executive Officer | 2015-11-30 |
Bracco Imaging SpA
 Bracco Imaging SpA Medical SpecialtiesHealth Technology Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy. | Corporate Officer/Principal | - |
| Roche Diagnostic Systems, Inc. /Microbiology Business/ | President | - |
Fortrea Clinical Research Unit, Inc.
 Fortrea Clinical Research Unit, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Clinical Research Unit, Inc. is a private company that engages in clinical research for pharmaceutical and biotechnology organizations. The company is based in Austin, TX. | Corporate Officer/Principal | - |
Bracco Diagnostics, Inc.
 Bracco Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ | Chief Executive Officer | - |
Training of Carlo Giovanni Medici
| University of Milan | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Bellco SRL
Bellco SRL Medical SpecialtiesHealth Technology Bellco SRL provides therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure. It offers haemodiafiltration therapies, dialysis machines equipment, haemodialysers, blood lines, catheters, concentrates, and sorbent cartridges; pathologies for acute patients; and altered haemodynamics, renal hypoperfusion, and low cardiac output therapeutic system for neonatal patients. The company was founded in 1972 and is headquartered in Mirandola, Italy.^ | Health Technology |
| Roche Diagnostic Systems, Inc. /Microbiology Business/ | Health Technology |
Ikonisys, Inc.
Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Health Technology |
Fortrea Clinical Research Unit, Inc.
Fortrea Clinical Research Unit, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Clinical Research Unit, Inc. is a private company that engages in clinical research for pharmaceutical and biotechnology organizations. The company is based in Austin, TX. | Commercial Services |
Bracco Diagnostics, Inc.
Bracco Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ | Health Technology |
Bracco Imaging SpA
Bracco Imaging SpA Medical SpecialtiesHealth Technology Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy. | Health Technology |
Bracco Imaging Scandinavia AB
Bracco Imaging Scandinavia AB Medical SpecialtiesHealth Technology Bracco Imaging Scandinavia AB manufactures and distributes diagnostics equipment. The company was founded in 2006 and is headquartered in Gothenburg, Sweden. | Health Technology |
Alzeca Biosciences, Inc.
Alzeca Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alzeca Biosciences, Inc. is a company based in Houston, TX. Alzeca is developing a proprietary intravenous contrast agent that targets Alzheimer's disease pathology. The company's targeted agent has shown the ability to detect early stage disease pathology with exceptional resolution and sensitivity using commonly available imaging techniques. The development of the agent was initiated through a collaboration between Dr. Ananth Annapragada and Dr. Jason Eriksen. The company was founded in 2012 by Jason Eriksen, Robin Mansukhani, Ananth Annapragada. The CEO is Carlo Giovanni Medici. | Commercial Services |
- Stock Market
- Insiders
- Carlo Giovanni Medici
